Skip to main content Skip to main navigation menu Skip to site footer
Archivio Italiano di Urologia e Andrologia

Editors: M. Maffezzini, Genova - G. Perletti, Varese | eISSN 2282-4197 - pISSN 1124-3562

  • About the Journal
  • Publication Ethics
  • Journal History
  • Editorial Board
  • Early Access
  • Current Issue
  • Archives
  • Special Issues
    • Overview
  • Copyright
  • Register
  • Login
  • Search
  • Contacts
  • News
1.4
Impact Factor
2025
2.4
CiteScore
2025
This journal has not published any issues.
1.4
Impact Factor 2025
2.4
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Androgen deprivation therapy (castration therapy) and pedophilia: What’s new

    Mauro Silvani, Nicola Mondaini, Alessandro Zucchi
    222-226
    30-09-2015
    https://doi.org/10.4081/aiua.2015.3.222
    10908
    Downloads: 5798
  • Medical management in locally advanced and metastatic prostate cancer: Does changes in treatment policy have any specific effect on PSA levels?

    Murat Bagcioglu, Cristian Surcel, Serkan Ozcan, Cristian Mirvald, Mehmet Ali Karagoz, Mert Ali Karadag, Emre Huri, Kemal Sarica
    282-286
    31-12-2017
    https://doi.org/10.4081/aiua.2017.4.282
    1402
    Downloads: 877
  • Impact of statins on metastatic castration-resistant prostate cancer patients receiving new hormonal agents

    Ana Marta Ferreira, Tiago Sousa, Roberto Jarimba, Vasco Quaresma, Pedro Nunes, Edgar Tavares da Silva, Arnaldo Figueiredo
    03-11-2025
    https://doi.org/10.4081/aiua.2025.14179
    1079
    Downloads: 594
  • Novel hormonal agents for metastatic Castration-Resistant Prostate Cancer: comparing outcomes. A single-center retrospective study

    Roberto Saldanha Jarimba, Miguel Nobre Eliseu, João Pedroso Lima, Vasco Quaresma, Pedro Moreira, Pedro Coelho Nunes, Edgar Tavares da Silva, Arnaldo José Figueiredo
    393-398
    20-12-2021
    https://doi.org/10.4081/aiua.2021.4.393
    1985
    Downloads: 1433
  • Effects of testosterone replacement on lipid profile, hepatotoxicity, oxidative stress, and cognitive performance in castrated wistar rats

    Oumayma Boukari, Wahid Khemissi, Soumaya Ghodhbane, Aida Lahbib, Olfa Tebourbi, Khemais Ben Rhouma, Mohsen Sakly, Dorsaf Hallegue
    15-11-2023
    https://doi.org/10.4081/aiua.2023.11593
    1700
    Downloads: 936
  • Efficacy and safety of second-line agents for treatment of metastatic castration-resistant prostate cancer progressing after docetaxel. A systematic review and meta-analysis

    Gianpaolo Perletti, Elena Monti, Emanuela Marras, Anne Cleves, Vittorio Magri, Alberto Trinchieri, Paul S. Rennie
    121-129
    07-07-2015
    https://doi.org/10.4081/aiua.2015.2.121
    11318
    Downloads: 6182
  • Bone pain palliation outcomes and possibility of Radium-223 re-treatment in mCRPC

    Viviana Frantellizzi, Julia Lazri, Mariano Pontico, Arianna Pani, Giuseppe De Vincentis
    01-10-2020
    https://doi.org/10.4081/aiua.2020.3.196
    1293
    Downloads: 924
  • Management of self-inflicted orchiectomy in psychiatric patient. Case report and non-systematic review of the literature

    Marco Garofalo, Alessandro Colella, Paolo Sadini, Lorenzo Bianchi, Giacomo Saraceni, Eugenio Brunocilla, Giorgio Gentile, Fulvio Colombo
    220-223
    30-09-2018
    https://doi.org/10.4081/aiua.2018.3.220
    2412
    Downloads: 1388
  • Prostate-specific antigen response after Abiraterone treatment in mCRPC: PSA as a predictor of overall survival

    Alexandre Mendonça Macedo, Rita Gameiro Marques, Margarida Cunha André, Nuno Silva Figueira, Miguel Leal Carvalho
    22-02-2023
    https://doi.org/10.4081/aiua.2023.11052
    1439
    Downloads: 1158
  • Prognostic value of neutrophil-to-lymphocyte ratio in mCRPC patients treated with abiraterone, enzalutamide and docetaxel: a retrospective single-center study

    Ana Marta Ferreira, André Rego, Vasco Quaresma, Roberto Jarimba, Edgar Tavares da Silva, Pedro Nunes, Arnaldo Figueiredo
    07-08-2026
    https://doi.org/10.4081/aiua.2026.15630
    247
    Downloads: 193
  • C reactive protein/Albumin ratio as predictor of prognosis in castration resistant metastatic prostate cancer

    João Lorigo, Edgar Tavares Silva, João Pedroso Lima, Vasco Quaresma, Rui Pedrosa, Arnaldo Figueiredo
    11-07-2023
    https://doi.org/10.4081/aiua.2023.11242
    1380
    Downloads: 758
  • Prognostic value of Ki67 and PSA-immunostaining in de novo metastatic hormone-sensitive prostate cancer

    Ana Marta Ferreira, Roberto Jarimba, André Rego, João Gama, Rui Almeida, Miguel Eliseu, Vasco Quaresma, Pedro Nunes, Vitor Sousa, Arnaldo Figueiredo
    31-03-2026
    https://doi.org/10.4081/aiua.2026.14731
    400
    Downloads: 300
  • Potential usefulness of CTC detection in follow up of prostate cancer patients. A preliminary report obtained by using Adnagene platform

    Giuseppe Albino, Francesca Vendittelli, Carmela Paolillo, Cecilia Zuppi, Ettore Capoluongo
    164-169
    31-12-2013
    https://doi.org/10.4081/aiua.2013.4.164
    2452
    Downloads: 2244
  • The role of immunotherapy in urological cancers

    Efe Bosnali, Enes Malik Akdas, Engin Telli, Kerem Teke, Onder Kara
    30-05-2024
    https://doi.org/10.4081/aiua.2024.12307
    2965
    Downloads: 1845
  • Reply to: Clarification to provide further understanding of the conduct and design of TROPIC: A Phase 3 trial of cabazitaxel versus mitoxantrone in patients with metastatic castration-resistant prostate cancer

    Gianpaolo Perletti
    74-75
    31-03-2016
    https://doi.org/10.4081/aiua.2016.1.74
    1831
    Downloads: 1296
  • BRCA mutations and prostate cancer: should urologist improve daily clinical practice?

    Simona Vatrano, Pietro Pepe, Ludovica Pepe, Nuccia Vella, Cristina Alario, Alessia Chiarandà, Chiara Taranto, Renato Scillieri, Cristina Mauceri, Filippo Fraggetta
    17-04-2025
    https://doi.org/10.4081/aiua.2025.13635
    2129
    Downloads: 939
  • Clarification to provide further understanding of the conduct and design of TROPIC: A Phase 3 trial of cabazitaxel versus mitoxantrone in patients with metastatic castration-resistant prostate cancer

    Johann de Bono, Liji Shen, Oliver Sartor
    72-73
    31-03-2016
    https://doi.org/10.4081/aiua.2016.1.72
    2700
    Downloads: 1380
  • Relugolix in treatment of prostate cancer: a review

    Ioannis Kyriazis, Themistoklis Bellos, Stamatios Katsimperis, Panagiotis Angelopoulos, Panagiotis Neofytoy, Ioannis Varkarakis, Andreas Skolarikos, Athanasios Papatsoris
    13-11-2025
    https://doi.org/10.4081/aiua.2025.14277
    1386
    Downloads: 757
  • Solitary prostatic cancer metastasis to the testis: A case report and lessons to learn

    Asmaa Ismail, Hazem Elmansy, Walid Shahrour, Owen Prowse, Ahmed Kotb
    265-266
    14-01-2020
    https://doi.org/10.4081/aiua.2019.4.265
    1475
    Downloads: 924
1 - 19 of 19 items
Make a Submission

authors

FOR AUTHORS
  • Guide for Authors
  • Benefits for Authors
  • How to write a Scientific paper
  • How to write a Review article
  • Article Processing Charge

reviewers

FOR REVIEWERS
  • Benefits for Reviewers
  • How to Review

indexing

INDEXING
  • PubMed
  • Scopus
  • Web of Science
  • Google Scholar
  • OpenAlex
  • CAS
  • ESCI
  • Analytics
Archivio Italiano di Urologia e Andrologia

is the official journal of the SIA, SIEUN, SIUrO and UrOP,  and it is published online by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.

pISSN: 1124-3562
eISSN: 2282-4197

Info

  • About
  • Editorial Board
  • News
  • Advertising

Submissions

  • Submission
  • Guidelines For Authors

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.